Koyfin Home > Directory > Health Care > Abbott Laboratories > Cash from Financing Activities

Abbott Laboratories Cash from Financing Activities Chart (ABT)

Abbott Laboratories annual/quarterly Cash from Financing Activities from 2010 to 2020.
  • Abbott Laboratories Cash from Financing Activities for the quarter ending September 09, 2020 was $-1,915m a -14.10% increase of 270m year over year
  • Abbott Laboratories Cash from Financing Activities for the last 12 months ending September 09, 2020 was $-4,177m a -2.68% increase of 112m year over year
  • Abbott Laboratories Annual Cash from Financing Activities for 2019 was $-4,289m a -142.27% increase of 6,102m from 2018
  • Abbott Laboratories Annual Cash from Financing Activities for 2018 was $-10,391m a 49.18% decrease of -5,110m from 2017
  • Abbott Laboratories Annual Cash from Financing Activities for 2017 was $-5,281m a 311.08% decrease of -16,428m from 2016
Other Cash Flow Metrics:
  • Abbott Laboratories Cash Flow from Operations for the quarter ending September 09, 2018 was $2,183m a 8.15% increase of 178m year over year
  • Abbott Laboratories Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $1,647m a 6.17% increase of 102m year over year
  • Abbott Laboratories Total Revenue for the quarter ending December 12, 2018 was $7,765m a 4.83% increase of 375m year over year
View Chart On Koyfin

Quarterly ABT Cash from Financing Activities Data

09/2020$-1,915m
06/2020$658m
03/2020$-735m
12/2019$-2,185m
09/2019$-513m
06/2019$-449m
03/2019$-1,142m
12/2018$-4,776m
09/2018$2,471m
06/2018$-1,631m

Annual ABT Cash from Financing Activities Data

2019$-4,289m
2018$-10,391m
2017$-5,281m
2016$11,147m
2015$-2,236m
2014$-2,742m
2013$-6,696m
2012$195m
2011$-6,423m
2010$-1,088m